TPH vs. PBYI

In the year-to-date period, TPH achieves a -16.35% return, which is significantly lower than PBYI's -1.64% return. Over the past 10 years, TPH has outperformed PBYI with an annualized return of 7.85%, while PBYI has yielded a comparatively lower -33.71% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tri Pointe Homes, Inc. (TPH) and Puma Biotechnology, Inc. (PBYI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TPH Sharpe Ratio is -0.52, which is comparable to the PBYI Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of TPH and PBYI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither TPH nor PBYI has paid dividends to shareholders.

The maximum TPH drawdown since its inception was -70.06%, smaller than the maximum PBYI drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for TPH and PBYI. For additional features, visit the drawdowns tool.

Tri Pointe Homes, Inc. (TPH) and Puma Biotechnology, Inc. (PBYI) have volatilities of 12.97% and 12.91%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Tri Pointe Homes, Inc. and Puma Biotechnology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.